Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Short-Term Debt issuances (2016 - 2017)

IGC Pharma (IGC) has disclosed Short-Term Debt issuances for 8 consecutive years, with $76911.0 as the latest value for Q4 2017.

  • Quarterly Short-Term Debt issuances rose 377.04% to $76911.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was -$448428.0 through Dec 2017, up 15.77% year-over-year, with the annual reading at -$476190.0 for FY2017, 61.98% up from the prior year.
  • Short-Term Debt issuances for Q4 2017 was $76911.0 at IGC Pharma, up from -$76911.0 in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $414321.0 in Q1 2015, with the low at -$766903.0 in Q3 2015.
  • Average Short-Term Debt issuances over 5 years is -$75444.4, with a median of -$2797.0 recorded in 2014.
  • The sharpest move saw Short-Term Debt issuances plummeted 25244.36% in 2015, then soared 377.04% in 2017.
  • Over 5 years, Short-Term Debt issuances stood at $101999.0 in 2013, then crashed by 143.45% to -$44322.0 in 2014, then skyrocketed by 148.39% to $21447.0 in 2015, then plummeted by 229.44% to -$27762.0 in 2016, then skyrocketed by 377.04% to $76911.0 in 2017.
  • According to Business Quant data, Short-Term Debt issuances over the past three periods came in at $76911.0, -$76911.0, and -$448428.0 for Q4 2017, Q3 2017, and Q1 2017 respectively.